Day: September 22, 2025

ATHENS, Greece, Sept. 22, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced the release of its Environmental, Social and Governance Report (the “ESG Report”), for the year ended December 31, 2024. The ESG Report provides an overview of the Company’s policies and practices relating to its environmental, social and governance commitments. The ESG Report is available on the Company’s website at www.dianashippinginc.com. Mrs. Semiramis Paliou, Director and Chief Executive Officer of the Company, stated: “We remain dedicated to our continuous efforts to shape a maritime future that is sustainable, equitable, and strategically positioned for long-term innovation and growth. Ultimately, we...

Federal agency selects Telos’ Xacta to streamline and automate cyber compliance ASHBURN, Va., Sept. 22, 2025 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced a new $2.2 million contract with a U.S. federal agency, which will deploy Telos’ flagship cyber governance, risk and compliance (GRC) platform, Xacta®. The customer will leverage Xacta’s capabilities to manage complex compliance requirements using the Telos FedRAMP High environment. The customer will also access premium support services and Xacta’s full suite of capabilities, equipping the customer with enhanced tools to reduce manual workloads and improve security oversight. The award highlights the continued adoption of Telos solutions...

UAB “Valstybės investicinis kapitalas” informs that on September 22, 2025, it successfully completed the redemption of the EUR 50 million bond issue ISIN code LT0000405664 in accordance with the terms of the issue. The bonds were issued in two distributions on September 15, 2021 with a yield of 0.045% and on November 25, 2021 with an annual interest rate of 0.05%.  Contact person: Vaidas DaktariunasValstybės investicinis kapitalas UAB, Chief Executive OfficerPhone: +370 618 29216E-mail: info@vika.lt

Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dawood Sayed, M.D., a nationally recognized leader in interventional pain medicine, to its Board of Directors, effective immediately. Dr. Sayed is a Professor of Anesthesiology and Pain Medicine at the University of Kansas Medical Center and currently serves as Division Chief of Pain Medicine, Director of Interventional Spine Services, and Director of the Center for Neuromodulation. With a robust clinical, academic, and policy background, he brings...

MINNEAPOLIS, Sept. 22, 2025 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that a late breaking abstract reporting clinical data from the Phase 3 VIKTORIA-1 trial has been selected for an oral presentation at the upcoming European Society of Medical Oncology (ESMO) Congress, being held October 17-21, 2025. The presentation will provide detailed efficacy and safety data from the PIK3CA wild-type cohort of the VIKTORIA-1 trial. Late Breaking Oral Presentation Details: Title: Gedatolisib + fulvestrant ± palbociclib vs fulvestrant in patients with HR+/HER2-/PIK3CA wild-type advanced breast cancer: First results from VIKTORIA-1 Abstract Number: 3535 Session Title: Proffered paper session 1: Breast Cancer, metastatic Date:...

Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional results from second dosing of second patient in the cohort SOUTH SAN FRANCISCO, Calif, Sept. 22, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company, today announced that it has dosed the third patient in the starting dose cohort of its Phase 1 clinical trial evaluating CER-1236 in acute myeloid leukemia (AML). Per protocol, three patients are planned at this lowest dose level, and enrollment of the third subject may complete the initial cohort pending the outcome of protocol-defined safety assessments, including the dose-limiting toxicity (DLT) evaluation period. Stephen Strickland, Jr., M.D., MSCI, Director of Leukemia...

Exploring potential partnerships and strategic opportunities for the Company’s stem cell therapy program in Alzheimer’s disease Alzheimer’s disease development program with positive data in successful Phase 1 and Phase 2a clinical trials Clear regulatory pathway following positive Type B meeting with U.S. FDA FDA has granted laromestrocel both Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation for the treatment of mild Alzheimer’s diseaseMIAMI, Sept. 22, 2025 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will participate in the Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa taking place October...

Prime 1,600-acre Nassau County property offers power, water, fiber connectivity and expansion capacity for phased AI and cloud infrastructure growth MIAMI, Sept. 22, 2025 (GLOBE NEWSWIRE) — NextNRG (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced it has secured a long-term lease option on 1,600 acres in Nassau County. The company is advancing plans for a potential deployment of a 200 MW smart microgrid that would utilize roughly 1,200 acres of the property. The remaining 400 acres are ideally positioned for hyperscale data center development, offering operators ample land in a location with power, water, and fiber already in place. Strategically located near Jacksonville International Airport, the property offers ample expansion capacity with direct...

Cardano’s Scalable, Peer-Reviewed Blockchain Strengthens Treasury Strategy LAKEWOOD, NJ, Sept. 22, 2025 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today announced that it has completed its first purchase of Cardano (ADA) under its recently launched Digital Asset Treasury (“DAT”) initiative. With this investment, Reliance strengthens its digital asset treasury by adding Cardano, recognized for its peer-reviewed, scalable blockchain, energy-efficient proof-of-stake design, and growing real-world adoption. This purchase follows Reliance’s initial purchase of Ethereum (ETH) earlier this month and reflects the Company’s ongoing commitment to building a diversified portfolio of leading digital assets. Reliance’s DAT initiative is designed to pursue long-term capital appreciation...

Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the high-throughput carrier screening market with a significantly expanded and enhanced suite of PureTarget products. The updated solutions leverage PacBio’s highly accurate HiFi sequencing technology to allow clinical laboratories to consolidate multiple specialized assays into a single, scalable test capable of resolving some of the most challenging genes associated with inherited conditions. Recent research shows that up to 71% of individuals carry at least one pathogenic variant, highlighting the growing importance of...